Expression of two drug-metabolizing cytochrome P450-enzymes in human salivary glands

Oral Diseases

Volumn 14, Issue 6, 2008, Pages 533-540

  Kragelund, C ^a,b   Hansen, C ^b   Torpet, L A ^b   Nauntofte, B ^b   Brosen K ^c   Pedersen, A M L ^b   Buchwald, C ^d   Therkildsen, M H ^d   Reibel, J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Cytochrome P 450; Immunohistochemistry; In situ hybridization; Salivary glands

Indexed keywords

CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; FORMALDEHYDE; MESSENGER RNA; PARAFFIN;

ACINAR CELL; ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; ORAL MUCOSAL DISEASE; PAROTID GLAND; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SALIVA; SALIVARY GLAND; SUBMANDIBULAR GLAND;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP3A; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PAROTID GLAND; SALIVARY DUCTS; SALIVARY GLANDS; SALIVARY GLANDS, MINOR; SALIVARY PROTEINS AND PEPTIDES; SEROUS MEMBRANE; SMOKING; SUBMANDIBULAR GLAND; XENOBIOTICS; YOUNG ADULT;

EID: 49749130057     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2007.01415.x     Document Type: Article

References (35)

1. Axell T, Rundquist L (1987). Oral lichen planus - a demographic study. Community Dent Oral Epidemiol 15 : 52 56.
2. Bar-Nun S, Kreibich G, Adesnik M, Alterman L, Negishi M, Sabatini DD (1980). Synthesis and insertion of cytochrome P-450 into endoplasmic reticulum membranes. Proc Natl Acad Sci U S A 77 : 965 969.
3. Baron JM, Holler D, Schiffer R et al (2001). Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116 : 541 548.
4. Batsakis JG (2003). Clinical pathology of oral cancer. In : Oral Cancer 1st Edition. Martin Dunitz : London, pp. 77 79.
5. Choo RE, Huestis MA (2004). Oral fluid as a diagnostic tool. Clin Chem Lab Med 42 : 1273 1287.
6. Damkier P, Hansen LL, Brosen K (1999). Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. Br J Clin Pharmacol 48 : 829 838.
7. Ding X, Kaminsky LS (2003). Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43 : 149 173.
8. Godtfredsen NS, Lucht H, Prescott E, Sorensen TI, Gronbaek M (2004). A prospective study linked both alcohol and tobacco to Dupuytren's disease. J Clin Epidemiol 57 : 858 863.
9. Hahn M, Hagedorn G, Kuhlisch E, Schackert HK, Eckelt U (2002). Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncol 38 : 486 490.
10. Hasler JA, Estabrook R, Murray M et al (1999). Human cytochromes P450. Mol Aspects Med 20 : 1 137.
11. Jusko WJ, Milsap RL (1993). Pharmacokinetic principles of drug distribution in saliva. Ann N Y Acad Sci 694 : 36 47.
12. Kato M, Chiba K, Hisaka A et al (2003). The intestinal first-pass metabolism of substrates of CYP3A4 and P-glycoprotein-quantitative analysis based on information from the literature. Drug Metab Pharmacokinet 18 : 365 372.
13. Kikuta Y, Kusunose E, Kusunose M (2001). Expression and induction of cytochrome P450s in rabbit parotid glands. Biochem Pharmacol 62 : 249 254.
14. Kivisto KT, Griese EU, Stuven T et al (1997). Analysis of CYP2D6 expression in human lung: implications for the association between CYP2D6 activity and susceptibility to lung cancer. Pharmacogenetics 7 : 295 302.
15. Lantini MS, Proto E, Puxeddu P, Riva A, Testa RF (1990). Fine structure of excretory ducts of human salivary glands. J Submicrosc Cytol Pathol 22 : 465 475.
16. Lesch CA, Squier CA, Cruchley A, Williams DM, Speight P (1989). The permeability of human oral mucosa and skin to water. J Dent Res 68 : 1345 1349.
17. Murray GI, Burke MD (1995). Immunohistochemistry of drug-metabolizing enzymes. Biochem Pharmacol 50 : 895 903.
18. Pedersen AM, Reibel J, Nauntofte B (1999). Primary Sjogren's syndrome (pSS): subjective symptoms and salivary findings. J Oral Pathol Med 28 : 303 311.
19. Pedersen AM, Bardow A, Jensen SB, Nauntofte B (2002). Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 8 : 117 129.
20. Rasmussen BB, Brix TH, Kyvik KO, Brosen K (2002). The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 12 : 473 478.
21. Riva A, Riva-Testa F (1973). Fine structure of acinar cells of human parotid gland. Anat Rec 176 : 149 165.
22. Riva A, Testa-Riva F, Del FM, Lantini MS (1976). Fine structure and cytochemistry of the intralobular ducts of the human parotid gland. J Anat 122 : 627 640.
23. Sato M, Sato T, Izumo T, Amagasa T (2000). Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral Oncol 36 : 267 271.
24. Siegle I, Fritz P, Eckhardt K, Zanger UM, Eichelbaum M (2001). Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics 11 : 237 245.
25. Standop J, Schneider MB, Ulrich A et al (2002a). The pattern of xenobiotic-metabolizing enzymes in the human pancreas. J Toxicol Environ Health A 65 : 1379 1400.
26. Standop J, Ulrich AB, Schneider MB, Buchler MW, Pour PM (2002b). Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas. Pancreatology 2 : 510 518.
27. Sundhedsstyrelsen (2005). Genstandsgrænser for voksne. 1st Edition. Danish National Board of Health : Copenhagen.
28. Tandler B, Erlandson RA (1972). Ultrastructure of the human submaxillary gland IV. Serous granules. Am J Anat 135 : 419 433.
29. Tandler B, Denning CR, Mandel ID, Kutscher AH (1969). Ultrastructure of human labial salivary glands I. Acinar secretory cells. J Morphol 127 : 383 407.
30. Tandler B, Denning CR, Mandel ID, Kutscher AH (1970). Ultrastructure of human labial salivary glands. 3 Myoepithelium and ducts. J Morphol 130 : 227 245.
31. Torpet LA, Kragelund C, Reibel J, Nauntofte B (2004). Oral adverse drug reactions to cardiovascular drugs. Crit Rev Oral Biol Med 15 : 28 46.
32. Vered M, Buchner A, Boldon P, Dayan D (2000). Age-related histomorphometric changes in labial salivary glands with special reference to the acinar component. Exp Gerontol 35 : 1075 1084.
33. Vondracek M, Xi Z, Larsson P et al (2001). Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 22 : 481 488.
34. Yokose T, Doy M, Taniguchi T et al (1999). Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Virchows Arch 434 : 401 411.
35. Zhou LX, Pihlstrom B, Hardwick JP, Park SS, Wrighton SA, Holtzman JL (1996). Metabolism of phenytoin by the gingiva of normal humans: the possible role of reactive metabolites of phenytoin in the initiation of gingival hyperplasia. Clin Pharmacol Ther 60 : 191 198.